Listed
Mainboard
NSE, BSE
MakeMyTrip India IPO
1 article · last updated 18 Nov 2026
Latest update · 18 Nov 2026
MakeMyTrip India Secures SEBI Approval for Domestic Public Listing via OFS
MakeMyTrip India secures SEBI approval for domestic IPO. The Nasdaq-listed OTA plans an offer for sale via MMT India and ibibo Group Holdings.
- Regulatory Milestone: SEBI issued final observations on November 6 for MakeMyTrip (India) Ltd's confidential draft filing submitted in July.
- Offering Mechanism: The IPO is structured as a secondary offer for sale of equity shares by parent MakeMyTrip and wholly owned unit ibibo Group Holdings (Singapore) Pte Ltd.
- Subsidiary Control Intact: MMT India will remain a controlled subsidiary post-offering, and its financial figures will continue to be consolidated into MakeMyTrip's financial reporting.
- Use of Net Inflows: Proceeds from the secondary sale will directly support the parent entity's cash reserves, funding inorganic expansion, long-term growth, and the repurchase of convertible securities.
- Talent Strategy: MMT India plans to utilize its listed status to deploy public equity incentives to retain top-tier technology and product professionals.
All articles on MakeMyTrip India
-
MakeMyTrip India Secures SEBI Approval for Domestic Public Listing via OFS
MakeMyTrip India secures SEBI approval for domestic IPO. The Nasdaq-listed OTA plans an offer for sale via MMT India and ibibo Group Holdings.
Overview
StatusListed
SegmentMainboard
ExchangeNSE, BSE
Articles1
Key dates
Listing06 Nov 2026
GMP is an unofficial grey-market indicator and can change quickly. This page is information only, not investment advice.